baber/WOPTO huggingface dataset:
Patent PT-1098009-E (PT)
Inventor: FISCHER GERNOT
IPC: C22C21/02
Filed: 2000-10-04
Abstract: Aluminum wrought alloy of the AlMgSi type contains alloying additions of (in wt.%): 0.6-2.0 magnesium, 0.6-3.0 silicon, 0.6-1.5 tin, 0.4-1.0 manganese, maximum 0.25 chromium and titanium, and impurities containing maximum 0.4 iron, maximum 0.1 copper and maximum 0.2 zinc.   An Independent claim is included for a process for the production of a continuously cast object made of the aluminum wrought alloy of the AlMgSi type comprising solution annealing during extrusion, quenching the extruded object and hardening.
Patent PT-1164085-E (PT)
Title: Laminated packaging material for paper container
Inventor: FRISK PETER
IPC: C08F10/02
Filed: 2000-01-25
Abstract: A paper packaging container is formed from the packaging material comparing constitution layers of at least an outside thermoplastic material layer, a paper substrate layer, and an inside thermoplastic material layer, wherein the inside thermoplastic material layer contains at least a linear low density polyethylene, and has properties parameters of an average density of 0.900-0.930, a predetermined peak melting point, a melt flow index of 5-15, and a swelling ratio of 1.3-1.8. The use of the packaging material allows easy filling and packaging to the packaging container and quick heat sealing, and results in more toughly and strongly sealed container, and the material can be used for achieving good sealing independently of the temperature of food contents and thus maintaining the non-scalping and quality preservability of the content product
Patent PT-1196148-E (PT)
Inventor: ORSOLINI PIERO
IPC: A61K38/00
Filed: 2000-04-14
Abstract: The present invention relates to microcapsules and methods of preparing microparticles with an extremely high encapsulation rate. In a O/W system, by skipping the step of a stable primary emulsion comprising organic solvent droplets, and by carefully setting the physico chemical parameters, microparticles produced by the method of the present invention show surprisingly good agent retention qualities.
Patent PT-1299367-E (PT)
Inventor: BERNDT TORSTEN
IPC: C07D301/08
Filed: 2001-09-05
Abstract: The invention relates to a new method for producing epoxides by oxidizing olefins in a homogeneous gas phase reaction, wherein ozone and NO2 and/or NO are reacted with the desired olefin under mild reaction conditions and without a catalyst. The inventive method can be carried out as a continuous, one-step method in a reactor according to FIG. 1, and requires very little technical input. Monoolefins having 2 to 16 carbon atoms and diolefins having 4 to 16 carbon atoms can be epoxidized.
Patent PT-1245407-E (PT)
Inventor: TARU SYRJAENEN
IPC: B42D15/10
Filed: 2002-03-27
Abstract: The invention relates to a layer-structured and flexible data sheet (2) in a security document comprising: a laser inscription layer (4) made of plastic material, on which at least some of the data of the data sheet can be printed utilizing laser inscription technique. In order to improve the bending endurance of the data sheet, a flexible back layer (5) that endures bending is attached to the laser inscription layer (4) by means of a laminate layer (6). <IMAGE>
Patent PT-1377251-E (PT)
Title: A cell therapy method for the treatment of tumors
Inventor: JACKSON MICHAEL R
IPC: A61K35/12
Filed: 2002-02-19
Abstract: T cell responses are often diminished in humans with a compromised immune system. We have developed a method to isolate, stimulate and expand naïve cytotoxic T lymphocyte precursors (CTLp) to antigen-specific effectors, capable of lysing tumor cells in vivo. This ex vivo protocol produces fully functional effectors. Artificial antigen presenting cells (AAPCs; e.g. from Drosophila melanogaster) transfected with multiple human HLA class I cancer antigens and defined accessory molecules, are used to stimulate CD8+ T cells from both normal donors and cancer patients. The class I molecules expressed to a high density on the surface of the Drosophila cells are empty, allowing for efficient loading of multiple peptides that results in the generation of polyclonal responses recognizing tumor cells endogenously expressing the specific peptides. The responses generated are robust, antigen-specific and reproducible if the peptide epitope is a defined immunogen. This artificial antigen expression system can be adapted to treat most cancers in a significant majority of the population.
Patent PT-1390577-E (PT)
Inventor: FABIO ZANELLO
IPC: D06F39/10
Filed: 2002-05-14
Abstract: The filter ( 3 ) comprises transversal walls ( 11 ) forming a labyrinth-like path with the inner surface of a hollow body ( 6 ) that is part of the water outlet circuit of the machine. On the peripheral edge of the said transversal walls ( 11 ) there are provided serrations ( 12 ) adapted to retain foreign bodies and break down the air bubbles that are present in the liquor taken in by the drain pump ( 4 ).
Patent PT-1454024-E (PT)
Inventor: CHRISTOPHE THEILLET
IPC: E05B17/00
Filed: 2002-10-28
Abstract: The invention concerns a device for locking and unlocking at will an actuating movement, for use in a safety lock, said device comprising at least a key (10) bearing authenticating encoding projections (12) in succession along the longitudinal axis (1) of the key and extending perpendicular to said axis, a mechanism for sensing the encoding projections (20), a mechanism for authenticating the encoding projections (30), and a rotor, the sensing mechanism (20) including a set of fittings (21) adopting respective positions controlled by the successive projections (12) of the key (10). The invention is characterized in that each projection (12) of the key (10) brought opposite a fitting (21) imposes by itself to the corresponding fitting (21) a specific angular direction in a plane transverse to the longitudinal axis of the key (10).The invention is applicable to a safety lock.
Patent PT-1476434-E (PT)
Inventor: BHATNAGAR NEERJA
IPC: A61P37/08
Filed: 2003-02-07
Abstract: The invention relates to a pyridazine derivative of formula (I), wherein the variables are as defined herein, pharmaceutical composition thereof, process for its preparation, and its pharmaceutical use.
Patent PT-1677996-E (PT)
Title: High-performance tyre for vehicle wheels
Inventor: GALIMBERTI MAURIZIO
IPC: B60C11/00
Filed: 2003-10-31
Abstract: Tire having at least one structural element including a crosslinked elastomeric material obtained by crosslinking a crosslinkable elastomeric composition containing (a) 100 phr of at least one diene elastomeric polymer; (b) 1 phr to 50 phr, preferably 2 phr to 40 phr, and more preferably 5 phr to 30 phr, of at least one layered material having an individual layer thickness of 0.01 nm to 30 nm, preferably 0.05 nm to 15 nm; (c) 0.1 phr to 15 phr, preferably 0.3 phr to 10 phr, of at least one methylene donor compound; and (d) 0.4 phr to 20 phr, preferably 0.8 phr to 15 phr of at least one methylene acceptor compound. Preferably, the at least one structural element is selected from bead filler, sidewall insert tread underlayer, or tread base.
Patent PT-1599703-E (PT)
Title: Navigation device with touch screen
Inventor: PINKUS AYAL
IPC: G06F3/0488
Filed: 2004-02-26
Abstract: A navigation device has a route ire calculation function. This is activated by the user touching the screen to task away from the normal navigation map mode to a menu screen which displays multiple types of route re-calculation options.
Patent PT-1641504-E (PT)
Title: Device for separating the constituents of a fluid
Inventor: JENTSCH KLAUS
IPC: A61M1/02
Filed: 2004-06-23
Abstract: The apparatus to separate the components of a fluid, and especially whole blood passed through a centrifuge, has a holder (6) to take the container (1) with the layered blood from the centrifuge for separation. A second holder (7) takes the container (2) for the first separated blood component. The containers are linked by flow channels (13-15). A second set of flow channels (16-18) extracts any gas from the second container.
Patent PT-1678166-E (PT)
Title: Protein kinase inhibitors
Inventor: HURLEY LAURENCE H
IPC: C07D487/02
Filed: 2004-10-14
Abstract: Protein kinase inhibitors are disclosed having utility in the treatment of protein kinase-mediated diseases and conditions, such as cancer. The compounds of this invention have the following structure: including steroisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein A is a ring moiety selected from: and wherein R1, R2, R3, X, Z, L1, Cycl1, L2 and Cycl2 are as defined herein. Also disclosed are compositions containing a compound of this invention, as well as methods relating to the use thereof.
Patent PT-1720440-E (PT)
Title: Endoscopy system and a pressure transmitting connector for said system
Inventor: FRANCISCO ANDRE
IPC: A61B1/015
Filed: 2005-03-02
Abstract: The system has a connector (17) including communication channels (19, 21) for communicating with connecting channels (13, 15) respectively. The channels (19, 21) are disposed with respect to a pressure detector that detects the pressure in the channels (19, 21). The connector is mounted on a mount (11) for communicating irrigation channel (5) and suction channel (9) with the channels (13, 15).
Patent PT-1913528-E (PT)
Title: Universal smart card
Inventor: BORRACCI FABRIZIO
IPC: G06K19/07
Filed: 2006-06-27
Abstract: Universal electronic card, of the smart card or intelligent card type, similar to a form of plastic card, with integrated circuital elements which are integrated in the thickness of the stratified card and within it at least one microchip, structured integrally with: i—a microprocessor associated to a memory; ii—an interchangeable flat battery within the card-thickness able to power-supply the microprocessor and the memory; iii—at least one data transmission device connected to the microprocessor and/or to the memory; iv—one fingerprint reader device integrated in it and to the processor system to read the imprint of the user, checking its authenticity before allowing the access at its various functions.
Patent PT-1896040-E (PT)
Title: Phosphoramidate alkylator prodrugs
Inventor: MATTEUCCI MARK
IPC: A61K33/243
Filed: 2006-06-29
Abstract: Phosphoramidate alkylator prodrugs can be used to treat cancer when administered alone or in combination with one or more other anti-neoplastic agents.
Patent PT-1854800-E (PT)
Title: Antitumoral derivatives of ecteinascidin et-743
Inventor: MUNT SIMON
IPC: A61K31/4995
Filed: 2002-07-17
Abstract: The present invention provides a compound of the general formula  Ia :   
wherein R 2 , R 4 , R 5  are each independently selected of H, C(=O)R', C(=O)OR', P=O(OR') 2 , substituted or unsubstituted C 1 -C 18  alkyl, substituted or unsubstituted C 2 -C 18  alkenyl, substituted or unsubstituted C 2 -C 18  alkynyl, substituted or unsubstituted aryl; 
wherein R 1  is C(=O)R" or C(=O)OR", and R" is an optionally substituted alkyl with at least 4 carbon atoms or an optionally substituted alkenyl, wherein the optional substituents are selected from aryl or heterocyclic; or R" is derived from an optionally protected amino acid; 
wherein R 6  and R 7  are both =O and the dotted lines indicate a quinone ring, or R 6  is -OR 3 , where R 3  is H, C(=O)R', C(=O)OR' substituted or unsubstituted C 1 -C 18  alkyl, substituted or unsubstituted C 2 -C 18  alkenyl, substituted or unsubstituted C 2 -C 18  alkynyl, substituted or unsubstituted aryl, R 7  is H, and the dotted lines indicate a phenyl ring; 
wherein X 2 , X 3 , X 4 , X 5 , X 6  are independently selected of H, OH, OR', SH, SR', SOR', SO 2 R', C(=O)R', C(=O)OR', NO 2 , NH 2 , NHR', N(R') 2 , NHC(=O)R', CN, halogen, substituted or unsubstituted C 1 -C 24  alkyl, substituted or unsubstituted C 2 -C 18  alkenyl, substituted or unsubstituted C 2 -C 18  alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaromatic; 
wherein X 1  is independently selected of OH, CN, (=O), or H; 
wherein each of the R' groups is independently selected from the group consisting of H, OH, NO 2 , NH 2 , SH, CN, halogen, C(=O)H, C(=O)CH 3 , CO 2 H, PO(OR') 2 , substituted or unsubstituted C 1 -C 18  alkyl, substituted or unsubstituted C 2 -C 18  alkenyl, substituted or unsubstituted C 2 -C 18  alkynyl, substituted or unsubstituted aryl; 
wherein when R 2 , R 3 , R 4 , and R 5  are substituted, the substituents are each independently selected from the group consisting of OH, OR', SH, SR', SOR', SO 2 R', C(=O)R', C(=O)OR', NO 2 , NH 2 , NHR', N(R') 2 , NHC(O)R', CN, halogen, =O, substituted or unsubstituted C 1 -C 18  alkyl, substituted or unsubstituted C 2 -C 18  alkenyl, substituted or unsubstituted C 2 -C 18  alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted heterocyclic.
Patent PT-2001537-E (PT)
Title: Variable dose inhalation device
Inventor: FLEMING SCOTT
IPC: A61M11/00
Filed: 2007-04-04
Abstract: An inhaler containing one or more vibrator mechanisms in one or more powder dispensing chambers for delivery of varying doses of a therapeutic agent or drug.
Patent PT-2049562-E (PT)
Title: Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer
Inventor: ROSA MARIO DE
IPC: A61K38/03
Filed: 2007-07-19
Abstract: Peptides and their functionally equivalent derivatives, in salified or non-salified form, with the general formula L 1 -X 1 -X 2 -X 3 -X 4 , wherein: 
L 1  is H, or acyl, or any natural or non-natural amino acid, optionally N-acylated, N-alkylated and/or C±-alkylated; 
X 1  and X 3 , which are equal or different, are any natural or non-natural basic amino acid, optionally N-alkylated and/or C±-alkylated; 
X 2  is any natural or non-natural amino acid, optionally N-alkylated and/or C±-alkylated, with the proviso that it is not glycine and amino acids mono-substituted on the ± carbon atom with a linear or cyclic alkyl group, from 1 to 10 carbon atoms, and amino acids mono-substituted on the ± carbon atom with a linear or cyclic alkyl group containing 4 to 10 carbon atoms, or amino acids mono-substituted on the ± carbon atom with an alkyl group containing 1 to 8 carbon atoms, optionally substituted with a carbamoyl, hydroxyl or aromatic group; 
X 4  is any natural or non-natural hydrophobic amino acid, optionally C±-alkylated and/or amidated at the C-terminal end, or any hydrophobic amino alcohol, or a hydrophobic gem-diamine, optionally N'-alkylated or N'-acylated.
Patent PT-2043796-E (PT)
Title: Method for producing panels ribbed on one or both sides
Inventor: MAIER FRANK
IPC: B21B1/00
Filed: 2007-07-23
Abstract: Method for the production of washers ribbed on one or both sides, wherein the rib profile either is achieved by rolling the raw material of the washers with the washers only after the rolling of the rib profile are punched out or by feeding the already punched out washers in the correct position to a pair of rolls or roll segments, respectively, with the rib structure being shaped by said tools.
Patent PT-1915943-E (PT)
Title: Central venous catheter with heat exchange properties
Inventor: PECOR ROBERT
IPC: A61B17/00
Filed: 2000-08-16
Abstract: An introducer sheath (42) for a central venous catheter (54) includes a sheath body (56) and a temperature sensor (80) mounted distally on the body (56). Also a jugular vein catheter system is disclosed having a heat exchange region and an oxygen sensor connected to an optical fiber.
Patent PT-2105157-E (PT)
Title: Improved airway device
Inventor: NASIR MUHAMMED ASLAM
IPC: A61M16/04
Filed: 2003-08-14
Abstract: An airway device for human or animal use comprising an airway tube having a distal end and a proximal end, the distal end of which is surrounded by a laryngeal cuff, adapted to fit anatomically over the laryngeal structure of a patient,  characterised in that  the device further comprises a buccal cavity stabiliser located on or around the airway tube between the laryngeal cuff and the proximal end of the tube, said buccal cavity stabiliser being adapted to nest with the anterior aspect of the patient's tongue, the size, shape and configuration of the buccal stabiliser being adapted to prevent rotational or side-to-side movement of the airway device in use.
Patent PT-2262076-E (PT)
Title: Power stabilization system and method employing a rechargeable battery system
Inventor: HASEGAWA YOSIHIRO
IPC: H02J7/34
Filed: 2001-02-02
Abstract: A power system stabilization system is provided between power generation equipment significantly fluctuating in output and a power system (3) required to maintain a predetermined voltage. In the power system stabilization system, a voltage detection device (51) and a current detection device (52) detect voltage and current, respectively, of the power system (3) and voltage and current thus detected are used to calculate a level of active power required and that of reactive power required which are referred to to provide charging and discharging from a rechargeable battery (10) to the power system via an A-D converter (40). <IMAGE>
Patent PT-2612850-E (PT)
Title: Delta crystalline form of the arginine salt of perindopril, a process for its preparation, and pharmaceutical compositions containing it
Inventor: LINOL JULIE
IPC: A61K31/403
Filed: 2013-01-04
Abstract: Delta crystalline form of perindopril L-arginine salt (I) having X-ray powder diffraction peaks measured using a diffractometer with a copper anticathode and expressed in terms of Bragg's angle 2 theta values as given in the specification, is new. Independent claims are included for: (1) the preparation of delta crystalline form of (I); and (2) a composition comprising an active agent and the delta crystalline form of (I) in combination with carriers. ACTIVITY : Cardiovascular-Gen; Hypotensive; Cardiant; Vasotropic. MECHANISM OF ACTION : Angiotensin I converting enzyme inhibitor.
Patent PT-577504-E (PT)
Inventor: O'NEILL VICTORIA A
IPC: A61K47/38
Filed: 1993-06-29
Abstract: The invention provides the use of niacin for the manufacture of a controlled release dosage form for the nocturnal treatment of hypercholesterolaemia in a single total daily dose.
Patent PT-628042-E (PT)
Inventor: BRAMBILLA ENZO
IPC: C07D457/12
Filed: 1993-11-26
Abstract: The present invention provides compounds of the formula (I)   <IMAGE>   wherein A, R1, R2 and R3 are defined as in the specification, or a pharmaceutically acceptable salt thereof. A process for their preparation and the pharmacetical compositions comprising them are also provided.
Patent PT-719143-E (PT)
Inventor: ANTONUCCI TAMMY
IPC: A61K31/41
Filed: 1994-09-09
Abstract: Treatment of impaired glucose tolerance, in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus comprises admin. of :(a)eg. a cpd. of formulae (I) or (II)(or a salt of these);(b) a cpd. of formula (IV) (or a cationic salt of (IV), or an acid addn. salt of (IV) when it contains a basic N atom);(c) a cpd. of formula (V) (or a cationic salt of (V), or an acid addn. salt of (V) when A or B is N);or (d) eg. a cpd. of formulae (VII) (or a tautomer, salt or solvate): R1, R2 = H or 1-5C alkyl; R3 = H, 1-6C aliphatic acyl,etc.;R4, R5 = H, 1-5C alkyl or 1-5C alkoxy; or R4+R5 = 1-4C alkylenedioxy; m = 1- 3; W = CH2 or CO etc.;Y, Z = O or NH; R11 = opt. substd. alkyl, alkoxy,etc.;L1, L2 = H or lower alkyl; or L1+L2 = alkylene;V = CH=CH, N=CH, CH=N or S; Za = H, 1-7C alkyl, 3-7C cycloalkyl,etc.;Z1 = H or 1-3C alkyl;q = 1- 3; A, B = CH or N, provided that they are not both N; X1 = S, O, SO2,etc.; s = 0-1; Y1 = CHR20 or R21; Z2 = CHR22, CH2CH2, CH=CH,etc.;R1y is not given; X2, X3 = H, Me, CF3, phenyl,etc. A2 = alkyl, opt. substd. aryl or opt. substd. aralkyl; A3 = a benzene ring with \~3 opt. substits.;R24 = H, alkyl, acyl, or opt. substd. aryl or aralkyl; or A2+R24 = 2-3C polymethylene (opt. substd. by alkyl or aryl, adjacent substits. together with the methylene carbon atoms opt. forming an opt. substd. phenylene gp.); R25, R26 = H; or R25+R26 = a bond; X4 = O or S; n = 2-6.
Patent PT-814759-E (PT)
Inventor: MSIKA PHILIPPE
IPC: A61Q1/12
Filed: 1996-03-14
Abstract: PCT No. PCT/FR96/00393 Sec. 371 Date Sep. 15, 1997 Sec. 102(e) Date Sep. 15, 1997 PCT Filed Mar. 14, 1996 PCT Pub. No. WO96/28136 PCT Pub. Date Sep. 19, 1996A sunscreen composition containing a synergic mixture of titanium and/or zinc oxide particles, characterized in that said particles are incorporated in paste-forming oils and/or esters and/or fatty alcohols and/or ethers selected so as to provide a wetting point of the incorporated titanium oxide particles and of the incorporated zinc oxide particles lower than about 5 and a flow point of said incorporatedparticles lower than about 30. The invention also provides a method for preparing said composition and the use thereof for protecting the skin against ultraviolet radiation and for maintaining the monocrystalline dispersion of minerals in the formulation and on the skin.
Patent PT-830137-E (PT)
Inventor: SHALABY SHALABY W
IPC: C07H13/02
Filed: 1996-05-24
Abstract: A copolymer comprising an N-acylated derivative, and a composition comprising said copolymer and a polypeptide, said polypeptide comprising at least one effective ionogenic amine, wherein at least 50 percent, by weight, of said polypeptide present in said composition is ionically bound to said polymer.
Patent PT-886652-E (PT)
Inventor: WEBER JAMES V
IPC: A61K38/00
Filed: 1996-10-22
Abstract: The invention relates to a method of manufacturing pulmonary surfactant protein by solubilizing the protein in ethanol by treatment with a fluorinated alcohol so that the protein may be formulated into liposomes by ethanolic injection.
Patent PT-991619-E (PT)
Inventor: TANIS STEVEN P
IPC: C07C275/42
Filed: 1998-06-23
Abstract: The present invention relates to small molecules according to the formula [I]:which are potent inhibitors of alpha4beta1 mediated adhesion to either VCAM or CS-1 and which can be used for treating or preventing alpha4beta1 adhesion mediated conditions in a mammal such as a human.
Patent PT-1147105-E (PT)
Inventor: KRAJCSI PETER
IPC: A61P9/00
Filed: 1999-12-07
Abstract: The invention relates to (-)-5,6-dihydro-5-(1-piperidinyl)-methyl-3-(3-pyridyl)-4H-1,2,4-oxadiazine to the therapeutical use thereof and to phamaceutical compositions containing the compounds as active ingredient.
Patent SG-108187-G (SG)
Title: Film cartridge manufacture and filling method and apparatus
IPC: G07B17/00
Filed: 1987-12-09
Abstract: @ Postal franking apparatus is described in which the information to be printed onto an envelope is stored electrically in a memory and is read out to form printing control signals for controlling a thermal printer containing thermally activable inking means at a printing station into which the envelope is placed.The inking means may comprise a ribbon carrying or impregnated with ink.A resiliently deformable backing member is located atthe printing station to accommodate variation in thickness of an envelope and content. In addition or alternatively a resiliently deformable printing head is employed.
Patent IE-820033-L (IE)
Title: Reverse buckling pressure relief disc
IPC: F17C13/12
Filed: 1982-01-08
Abstract: A reverse buckling disc having a central domed region, an outer flange and an integral transitional region interconnecting the flange and the domed central region wherein the included angle of the transitional region is greater than the included angle of the domed region, such that the reversing pressure of the disc is determined by the angle of the transitional region rather than by the height of the dome.
[US4436218A]